Condensed Consolidated Statements of Stockholders' (Deficit) Equity - USD ($) $ in Thousands	Preferred Stock	Common stock	Additional paid-in capital	Accumulated other comprehensive income / (loss)	Accumulated deficit	Total
Beginning Balance at Dec. 31, 2023			$ 104,757	$ (1,578)	$ (95,066)	$ 8,113
Beginning Balance (in shares) at Dec. 31, 2023	13,765	889,668
Stock-based compensation expense			107			107
Issuance of stock awards			21			21
Issuance of stock awards (in Shares)		3,400
Issuance of common stock to vendor			53			53
Issuance of common stock to vendor (in shares)		50,000
Conversion of Preferred stock into common stock (in shares)	(3,817)	436,294
Exchange of Preferred stock into common stock warrants (in shares)	(6,356)
Deemed dividend on extinguishment of Preferred stock			7,069		(7,094)	(25)
Exercise of warrants into common stock (in shares)		388
Foreign currency translation adjustment				(18)		(18)
Net loss					(1,696)	(1,696)
Ending Balance at Mar. 31, 2024			112,007	(1,596)	(103,856)	6,555
Ending Balance (in shares) at Mar. 31, 2024	3,592	1,379,750
Beginning Balance at Dec. 31, 2023			104,757	(1,578)	(95,066)	8,113
Beginning Balance (in shares) at Dec. 31, 2023	13,765	889,668
Foreign currency translation adjustment						156
Net loss						(4,795)
Ending Balance at Jun. 30, 2024			112,965	(1,422)	(106,955)	4,588
Ending Balance (in shares) at Jun. 30, 2024	1,106	1,721,900
Beginning Balance at Mar. 31, 2024			112,007	(1,596)	(103,856)	6,555
Beginning Balance (in shares) at Mar. 31, 2024	3,592	1,379,750
Stock-based compensation expense			207			207
Issuance of common stock to vendor			48			48
Issuance of common stock to vendor (in shares)		50,000
Conversion of Preferred stock into common stock (in shares)	(2,486)	284,150
Exercise of warrants into common stock			3			3
Exercise of warrants into common stock (in shares)		8,000
Fair value of warrants reclassified from liability to equity			700			700
Foreign currency translation adjustment				174		174
Net loss					(3,099)	(3,099)
Ending Balance at Jun. 30, 2024			112,965	(1,422)	(106,955)	4,588
Ending Balance (in shares) at Jun. 30, 2024	1,106	1,721,900
Beginning Balance at Dec. 31, 2024			122,316	(1,105)	(114,620)	6,591
Beginning Balance (in shares) at Dec. 31, 2024	856	3,590,217
Stock-based compensation expense			250			250
Issuance of common stock to vendor			85			85
Issuance of common stock to vendor (in shares)		30,000
Foreign currency translation adjustment				(1,005)		(1,005)
Net loss					(2,134)	(2,134)
Ending Balance at Mar. 31, 2025			122,651	(2,110)	(116,754)	3,787
Ending Balance (in shares) at Mar. 31, 2025	856	3,620,217
Beginning Balance at Dec. 31, 2024			122,316	(1,105)	(114,620)	$ 6,591
Beginning Balance (in shares) at Dec. 31, 2024	856	3,590,217
Issuance of common stock to vendor (in shares)						160,000
Foreign currency translation adjustment						$ (3,069)
Net loss						(4,534)
Ending Balance at Jun. 30, 2025			123,201	(4,174)	(119,154)	(127)
Ending Balance (in shares) at Jun. 30, 2025		4,441,165
Beginning Balance at Mar. 31, 2025			122,651	(2,110)	(116,754)	3,787
Beginning Balance (in shares) at Mar. 31, 2025	856	3,620,217
Stock-based compensation expense			260			260
Issuance of common stock to vendor			290			290
Issuance of common stock to vendor (in shares)		130,000
Conversion of Preferred stock into common stock (in shares)	(856)	690,788
Exercise of warrants into common stock (in shares)		160
Foreign currency translation adjustment				(2,064)		(2,064)
Net loss					(2,400)	(2,400)
Ending Balance at Jun. 30, 2025			$ 123,201	$ (4,174)	$ (119,154)	$ (127)
Ending Balance (in shares) at Jun. 30, 2025		4,441,165